Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
4.660
+0.060 (1.30%)
Feb 27, 2026, 3:00 PM CST
-8.63% (1Y)
| Market Cap | 3.28B -17.1% |
| Revenue (ttm) | 430.61M +55.3% |
| Net Income | -118.38M |
| EPS | -0.16 |
| Shares Out | 703.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,435,720 |
| Average Volume | 7,769,534 |
| Open | 4.580 |
| Previous Close | 4.600 |
| Day's Range | 4.510 - 4.680 |
| 52-Week Range | 3.450 - 7.050 |
| Beta | 0.34 |
| RSI | 43.93 |
| Earnings Date | Apr 25, 2026 |